Position in JNJ
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$7,294,018
-$120,091 QoQ
Shares Held
28,720
-5.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.04%
of 13F equity value
Holder Rank
#1,310
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PFG Advisors holds $28,669,367 across 8 Drug Manufacturers - General names. JNJ ranks #1 (25.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
28,720 | $7,294,018 | |
| 2 | ABBV |
AbbVie Inc.
|
22,305 | $5,612,830 | |
| 3 | LLY |
ELI LILLY & Co
|
4,488 | $5,383,042 | |
| 4 | AMGN |
Amgen Inc
|
14,633 | $5,298,901 | |
| 5 | MRK |
Merck & Co., Inc.
|
31,306 | $4,022,821 | |
| 6 | PFE |
Pfizer Inc
|
15,983 | $384,870 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,755 | $348,066 | |
| 8 | AZN |
Astrazeneca PLC
|
1,713 | $324,819 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,294,018 | 28,720 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $7,414,109 | 30,331 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $5,803,084 | 28,041 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $8,117,316 | 43,778 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $6,010,865 | 39,351 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $5,899,592 | 35,574 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $4,192,244 | 28,988 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $4,826,146 | 29,780 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $4,681,066 | 32,027 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $5,042,148 | 31,874 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $5,075,084 | 32,379 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $5,092,402 | 32,696 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $9,316,789 | 56,288 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $8,358,685 | 53,927 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $9,415,621 | 53,301 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $8,310,449 | 50,872 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $8,725,681 | 49,156 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $8,480,632 | 47,851 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $7,987,771 | 46,693 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $7,441,435 | 46,077 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $7,686,109 | 46,656 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $7,511,452 | 45,704 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $3,735,099 | 23,733 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $3,475,305 | 23,343 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $3,183,863 | 22,640 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $2,917,380 | 22,248 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||